申请人:Takeda Chemical Industries, Ltd.
公开号:US06011046A1
公开(公告)日:2000-01-04
A compound of the formula (I): ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 independently represent H, an optionally acylated hydroxyl group, an optionally substituted amino group, an optionally substituted alkoxy group or an optionally substituted hydrocarbon group, or R.sup.2 and R.sup.3 may form an optionally substituted hydrocarbon ring; R.sup.4 represents an alkyl group; R.sup.5 represents an optionally substituted hydroxyl group; R.sup.6 and R.sup.7 independently represent an optionally substituted hydrocarbon group or R.sup.6 and R.sup.7 form an optionally substituted ring; m represents 1 or 2; and n represents an integer of 1 to 5; or a hydroquinone derivative or a salt thereof has lipoperoxide formation inhibitory effect and is useful as a medicine for treating or preventing central nervous system disorders, diseases in the circulatory system, etc.
式(I)的化合物:##STR1##其中,R.sup.1、R.sup.2和R.sup.3独立地表示H、可选酰化的羟基、可选取代的氨基、可选取代的烷氧基或可选取代的碳氢基,或R.sup.2和R.sup.3可形成可选取代的碳氢环;R.sup.4表示烷基;R.sup.5表示可选取代的羟基;R.sup.6和R.sup.7独立地表示可选取代的碳氢基或R.sup.6和R.sup.7形成可选取代的环;m表示1或2;n表示1至5的整数;或羟基苯醌衍生物或其盐具有抑制脂质过氧化物形成的作用,可用作治疗或预防中枢神经系统疾病、循环系统疾病等的药物。